Kevin Alby

16PUBLICATIONS
59CO-AUTHORS
Major global burdens of diseaseEnvironmental epidemiologyMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 08, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.

Natalie A Mackow, Wanying Shao, Lizhao Ge

|Oct 13, 2025
Multicenter evaluation of the QuickMIC® rapid AST system in clinical practice: impact on turnaround time compared to routine AST systems.

Anna Olsson, Alexandra Rafeletou, Amanda Åman

|Jan 16, 2025
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Tessa M Andermann, Dylan Brown, Thomas Holowka

|Jan 18, 2024
Efficacy of noncarbapenem therapy for the treatment of ceftriaxone-resistant Enterobacterales outside the urinary tract.

Ethan P Rausch, Kevin Alby, William Wilson

Pageof 3